Ingram Micro Commerce & Lifecycle Services Selected to Operate Zalando’s Inbound Distribution Center Near Berlin, Germany
4.10.2021 07:00:00 EEST | Business Wire | Press release
Ingram Micro Commerce & Lifecycle Services, a leading provider of global supply chain management and ecommerce logistics solutions, today announced that it has been selected by Zalando, Europe's leading online platform for fashion and lifestyle, to manage the company’s inbound distribution center near Berlin, Germany.
Zalando’s distribution center in Großbeeren, near Berlin, became operational in March 2021, offers 17.000 square meters of space and is strategically located near one of Germany’s strongest consumer markets. The warehouse is used to distribute products among other Zalando fulfillment centers, helping to balance inventory among facilities and increase the availability of products based on consumer demand in given regions.
“Ingram Micro is proud to extend our collaboration with Zalando into a new area of business,” said Dietmar Schenzel, executive director, Ingram Micro Commerce & Lifecycle Services. “We have seen the company through immense growth — from the launch of their ecommerce fulfillment operations through their evolution to become what is now the biggest online fashion platform in Europe. Such a journey speaks to the value of a truly strategic collaboration.”
The inbound distribution center is the third facility in Zalando’s network to be operated by Ingram Micro. Ingram Micro also manages Zalando’s fulfillment centers near Stockholm, Sweden, and Rotterdam, Netherlands.
About Ingram Micro Commerce & Lifecycle Services
Ingram Micro Commerce & Lifecycle Services provides supply chain solutions that go beyond connecting supply and demand. From cross-border fulfillment to dropship and returns management, IT asset disposition, remarketing and more, our solutions drive growth, enhance ROI and protect our clients. We proudly serve customers across a broad spectrum of industries — from fast-growing brands to Global 2000 enterprises — and are dedicated to facilitating their success through our global warehouse network, world-class technology, strategic partnerships and decades of expertise in the logistics, mobile device and ITAD industries. To learn more, visit: www.ingrammicroservices.com.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20211003005001/en/
Contact information
Lauren Jow
Global Brand Manager
Lauren.jow@ingrammicro.com
Ingram Micro Commerce & Lifecycle Services
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
LTM Collaborates with Chainguard to Strengthen Software Supply Chain Security through BlueVerse™ RightLogic6.8.2026 14:30:00 EEST | Press release
LTM, the Business Creativity partner to the world's largest enterprises, today announced a strategic collaboration with Chainguard, the trusted source for open source, to strengthen software supply chain security through BlueVerse™ RightLogic, LTM's cybersecurity assessment and risk assurance framework. The collaboration enables organizations to strengthen security while maintaining the speed and agility required for AI-enabled software development. With BlueVerse RightLogic, LTM combines AI-powered cyber risk assessment with a growing ecosystem of technology partners to help enterprises identify, assess, and remediate cyber exposure while accelerating AI adoption. Chainguard strengthens the BlueVerse RightLogic ecosystem by helping enterprises secure open-source components from the outset, complementing LTM's cybersecurity services to close the gap between AI-speed discovery and enterprise-speed remediation. As AI adoption accelerates, complex software supply chains and growing relian
teamLab Borderless in Tokyo Welcomes Over 4 Million Visitors from more than 185 Countries6.8.2026 14:07:00 EEST | Press release
teamLab Borderless: MORI Building DIGITAL ART MUSEUM (teamLab Borderless) in Tokyo has welcomed over 4 Million visitors as of July 31, 2026, approximately 2 years and 5 months since its opening.*1 This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260806672709/en/ teamLab Borderless: MORI Building DIGITAL ART MUSEUM in Tokyo Welcomes Over 4 Million Visitors from more than 185 Countries These visitors arrived from more than 185 countries and regions. International visitors account for approximately 70% of the total number. Many of these international visitors travel from distant countries and regions, including the United States, Australia, Canada, the United Kingdom and Germany. Among those who visited Japan between February 2024 and June 2026, approximately 1 in every 12 travelers from the United States, and 1 in every 9 travelers from Australia visited teamLab Borderless.*2 teamLab Borderless was selected by the U.S. based int
Compass Pathways to Participate in Canaccord Genuity's 46th Annual Growth Conference on August 12, 20266.8.2026 14:00:00 EEST | Press release
Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to unlocking urgently needed new treatment options in mental health care, announced today that management will attend the Canaccord Genuity's 46th Annual Growth Conference on August 12, 2026, and will participate in a fireside chat at 8:00am ET. Management will also participate in the Stifel Biotech Summit in Newport, Rhode Island, on August 10, 2026. A live audio webcast of this event will be accessible from the “Events” page of the Investors section of the Compass website. A replay of the webcast will be accessible for 30 days following each event. About Compass Pathways We believe mental health patients deserve the possibility of a better future. Compass Pathways plc (Nasdaq: CMPS) is a biotechnology company dedicated to unlocking urgently needed new treatment options in mental health care. Our initial focus is developing COMP360 psilocybin, a proprietary, investigational, synthetic psilocybin treatment under eva
Purina Named as First Publicly Announced NIQ ConnectAI Charter Client6.8.2026 13:45:00 EEST | Press release
NielsenIQ (NYSE: NIQ), a global leader in consumer intelligence, today named Purina as the first publicly announced client in its ConnectAI Charter Program. The announcement follows NIQ’s launch of the program with five global organizations across personal care, pet care, beauty and beverages, with additional client announcements and case studies expected as engagements advance. Through ConnectAI, NIQ forward-deployed engineers and data scientists are working within Purina’s technology environment to explore how NIQ consumer and market intelligence can support everyday AI-enabled workstreams and help teams access relevant insights more efficiently. "Understanding the needs of pet owners requires a clear view of how consumer behaviors, shopping habits, and category trends are evolving,” said Brian Donovan, Strategy and Insights, Purina. “Purina is working with NIQ to explore how its trusted intelligence can be incorporated into Purina’s everyday, AI-enabled workstreams, helping our team
Compass Pathways Working with U.S. Department of Veterans Affairs for Investigational Study of Psilocybin6.8.2026 13:30:00 EEST | Press release
Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to unlocking urgently needed new treatment options in mental health care, announced today it is working with the U.S. Department of Verterans Affairs (VA) on a multi-site randomized controlled clinical trial. The study will evaluate the safety and efficacy of COMP360 psilocybin in the treatment of treatment-resistant depression (TRD) in veterans, including those with concurrent post-traumatic stress disorder (PTSD). The trial, titled "Psilocybin Intervention for Veterans Overcoming Treatment-Resistant Depression," or PIVOT, reflects VA’s commitment to pursuing innovative solutions for veterans who have not responded to existing treatments. Compass will donate the study drug - COMP360, a synthetic, proprietary pharmaceutical-grade formulation of psilocybin optimized for stability and purity. Compass will support the education and training of the investigators and their training team through the provision of training
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom